Status:
NOT_YET_RECRUITING
Assessing the Effectiveness and Safety of Pericapsular Nerve Group (PENG) Block in Hip Fracture Patients on Antithrombotic Therapy
Lead Sponsor:
Alexandria University
Conditions:
Hip Fracture
Antithrombotic Therapy
Eligibility:
All Genders
65-85 years
Phase:
NA
Brief Summary
PENG block will be done on patients with hip fracture either receiving antithrombotic therapy or not under ultrasound guidance
Detailed Description
Patients will be randomized into two groups: Group A (Antithrombotic Therapy Group): 50 Patients on continuous antithrombotic therapy will receive BENG block. Group C (Control Group): 50 Patients wi...
Eligibility Criteria
Inclusion
- Age 65 years or older
- diagnosis of hip fracture
- scheduled for surgical intervention within 48 hours
- Informed consent obtained.
Exclusion
- Allergy to local anesthetics,
- Contraindications to the PENG block
- inability to provide informed consent.
Key Trial Info
Start Date :
September 17 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 17 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06582667
Start Date
September 17 2024
End Date
April 17 2025
Last Update
September 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine
Alexandria, Egypt